blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1223975

EP1223975 - MUCOSAL DTPa VACCINES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.03.2010
Database last updated on 23.04.2024
Most recent event   Tooltip26.03.2010No opposition filed within time limitpublished on 28.04.2010  [2010/17]
Applicant(s)For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena (SI) / IT
[2009/21]
Former [2007/04]For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena SI / IT
Former [2004/02]For all designated states
Chiron S.r.l.
Via Fiorentina, 1
53100 Siena / IT
Former [2002/30]For all designated states
Chiron S.P.A.
Via Fiorentina, 1
53100 Siena / IT
Inventor(s)01 / RAPPUOLI, Rino
Chiron S.p.A., Via Fiorentina, 1
I-53100 Siena / IT
02 / PIZZA, Mariagrazia
Chiron S.p.A., Via Fiorentina, 1
I-53100 Siena / IT
 [2002/30]
Representative(s)Hallybone, Huw George, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2002/30]Hallybone, Huw George, et al
Carpmaels and Ransford, 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date00962770.428.09.2000
[2002/30]
WO2000IB01440
Priority number, dateGB1999002306029.09.1999         Original published format: GB 9923060
[2002/30]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0122993
Date:05.04.2001
Language:EN
[2001/14]
Type: A2 Application without search report 
No.:EP1223975
Date:24.07.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 05.04.2001 takes the place of the publication of the European patent application.
[2002/30]
Type: B1 Patent specification 
No.:EP1223975
Date:20.05.2009
Language:EN
[2009/21]
Search report(s)International search report - published on:EP25.10.2001
ClassificationIPC:A61K39/116, A61K39/39, A61K39/106, A61K39/108, A61P31/04
[2002/30]
CPC:
A61K39/39 (EP,US); A61K39/0018 (EP,US); A61K39/05 (EP,US);
A61K39/08 (EP,US); A61K39/099 (EP,US); A61P31/04 (EP);
A61P31/10 (EP); A61P37/04 (EP); A61K2039/541 (EP,US);
A61K2039/543 (EP,US); A61K2039/545 (EP,US); A61K2039/55544 (EP,US);
Y10S424/832 (EP,US); Y10S530/825 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/30]
TitleGerman:MUKOSALE DTPA IMPFSTOFFE[2002/30]
English:MUCOSAL DTPa VACCINES[2002/30]
French:VACCINS DTPa POUR VACCINATION MUCOSALE[2008/36]
Former [2002/30]VACCINS DTPA DES MUQUEUSES VACCINES
Entry into regional phase25.04.2002National basic fee paid 
25.04.2002Designation fee(s) paid 
25.04.2002Examination fee paid 
Examination procedure25.04.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
25.04.2002Examination requested  [2002/30]
26.11.2004Despatch of a communication from the examining division (Time limit: M04)
16.03.2005Reply to a communication from the examining division
24.05.2006Despatch of a communication from the examining division (Time limit: M06)
04.12.2006Reply to a communication from the examining division
29.02.2008Despatch of a communication from the examining division (Time limit: M04)
27.06.2008Reply to a communication from the examining division
28.10.2008Communication of intention to grant the patent
02.03.2009Fee for grant paid
02.03.2009Fee for publishing/printing paid
Opposition(s)23.02.2010No opposition filed within time limit [2010/17]
Fees paidRenewal fee
25.04.2002Renewal fee patent year 03
24.09.2003Renewal fee patent year 04
23.09.2004Renewal fee patent year 05
05.09.2005Renewal fee patent year 06
08.09.2006Renewal fee patent year 07
05.09.2007Renewal fee patent year 08
31.03.2008Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP0462534  (SCLAVO SPA [IT]) [A] 1-11 * page 3, line 30 - page 4, line 45 * * page 14, line 1 - line 43; table X * * claims 1-6,13,14 *;
 [X]US5182109  (TAMURA SHINICHI [JP], et al) [X] 1,3,8 * column 1, line 36 - line 43 * * column 2, line 29 - line 61 * * column 8, line 51 - column 9, line 16 * * examples 5,15 * * claims 1-4 *;
 [X]WO9321950  (MEDEVA HOLDINGS BV [NL], et al) [X] 1,3,7-13 * page 4, line 15 - page 6, line 2 * * page 8, line 20 - page 9, line 8 * * claims 1-5,11-14,17-19 *;
 [A]WO9702348  (BIOCINE SPA [IT], et al) [A] 2,12,13 * page 1, line 5 - line 16 * * page 6, line 33 - page 7, line 2 * * page 8, line 20 - page 9, line 13 * * page 47, line 23 - page 49, line 22 * * claims 1,4,10,11 *;
 [Y]  - RYAN E ET AL, "The adjuvant action of mutants of the heat labile toxin of E. coli for a nasally delivered acellular pertussis vaccine.", IMMUNOLOGY LETTERS, 10th International Congress of Mucosal Imunology;Amsterdam, Netherlands; June 27-July 1, 1999, (19990615), vol. 69, no. 1, ISSN 0165-2478, page 59, XP000982713 [Y] 1-6,8-13 * the whole document *
 [YD]  - DEL GIUDICE GIUSEPPE ET AL, "Molecular basis of vaccination.", MOLECULAR ASPECTS OF MEDICINE, (199802), vol. 19, no. 1, ISSN 0098-2997, pages 1 - 70, XP002162795 [YD] 1-6,8-13 * page 23, line 29 - page 25, line 15 * * page 30, line 5 - line 9; table 2 * * page 33, line 8 - page 36, line 13 * * page 43, line 11 - page 46, line 39 *
 [PX]  - RYAN ELIZABETH J ET AL, "Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: Differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.", INFECTION AND IMMUNITY, (199912), vol. 67, no. 12, ISSN 0019-9567, pages 6270 - 6280, XP002162796 [PX] 1-13 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.